Walgreen to pay more than $2.85 million to settle US overbilling charges
March 27 (Reuters) - Walgreen (WBA.O), opens new tab will pay more than $2.85 million to settle whistleblower allegations that the pharmacy overbilled Medicaid programs in Georgia and Massachusetts for generic medications, the U.S. Department of Justice said on Thursday.
The settlement partially resolves claims against the Walgreens Boots Alliance unit brought under the federal, Georgia and Massachusetts False Claims Act.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Walgreen pharmacies were accused of having from 2008 to 2023 submitted elevated "usual and customary" prices for some generic medications to the MassHealth and Georgia Medicaid programs, causing those programs to pay more for the medications than they should have.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
13 minutes ago
- Reuters
Riyadh Air to order 25 Airbus A350 jets at air show, sources say
PARIS, June 11 (Reuters) - Saudi startup Riyadh Air is set to place a firm order for 25 Airbus ( opens new tab A350-1000 jets, industry sources said. The airline, previously reported to be considering buying up to 50 jets, will finalise the order at next week's Paris Airshow, where fellow Public Investment Fund subsidiary AviLease is also seen as close to a deal for 40 Airbus planes. Both Saudi companies have also placed orders for Boeing jets. Airbus and Riyadh Air declined to comment.
Reuters
23 minutes ago
- Reuters
Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study
June 11 (Reuters) - Novavax's (NVAX.O), opens new tab experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.
Reuters
27 minutes ago
- Reuters
Nvidia, Perplexity partner with European firms to boost local AI models
SAN FRANCISCO, June 11 (Reuters) - Nvidia and artificial intelligence search firm Perplexity on Wednesday said they are partnering with more than a dozen AI firms in Europe and the Middle East to refine those firms' AI technologies and distribute them to local businesses. Nvidia (NVDA.O), opens new tab said it will work with model makers in France, Germany, Italy, Poland, Spain and Sweden to help make AI models in local languages become what are called reasoning models, which are capable of carrying out more complicated tasks. AI technologies built in English and Chinese have started to shift to that technology, but that transition is more difficult in languages where less training data is available. Kari Briski, vice president of generative AI software for enterprise at Nvidia, said the company will help model makers generate new data - known as synthetic data - in local languages to help improve them. "We're doing a lot of synthetic data generation to bring to these low-resource languages and translating our reasoning data so that they can train on it," Briski said in an interview Tuesday. "Europe needs strong models that reflect each nation's unique language and culture." Once those local models are trained, Perplexity will help distribute them in Europe, where businesses can run them in local data centers and use them to carry out business tasks such as researching a new topic. Perplexity CEO Aravind Srinivas said Germany is already Perplexity's second largest market by revenue. "That's the kind of system we are heading to in the future, where models are basically doing a few hours' worth of work in one single prompt," Srinivas said. The deal was part of a number of announcements Nvidia made at an AI conference in Paris on Wednesday. Nvidia and Perplexity did not disclose any financial terms of the deal.
